60 degrees pharmaceuticals announces closing of up to $10 million public offering

Washington, july 16, 2025 (globe newswire) -- 60 degrees pharmaceuticals, inc. (the “company” or “60 degrees”) (nasdaq: sxtp; sxtpw), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced the closing of its previously announced public offering of 2,631,578 shares of the company's common stock (or pre-funded warrants in lieu thereof) and accompanying series a-1 warrants to purchase up to 2,631,578 shares of common stock and short-term series a-2 warrants to purchase up to 2,631,578 shares of common stock, at a combined offering price of $1.90 per share of common stock (or per pre-funded warrant in lieu thereof) and accompanying warrants. the series a-1 warrants have an exercise price of $1.90 per share, are exercisable upon issuance and expire five years thereafter.
SXTP Ratings Summary
SXTP Quant Ranking